Pure Extracts Raises $8.5 Million In Upsized Special Warrant Financing

Pure Extracts (CSE: PULL) yesterday announced the closure of its offering of special warrants, raising gross proceeds of $8.5 million. The financing was closed via the closing of two tranches within the financing, with the final tranche consisting of $5.5 million in gross proceeds.

A total of 16.9 million special warrants were issued under the offering, with special warrants sold at a price of $0.505 per each. Each special warrant converts to one unit of the company, with each unit containing one common share and one half of a common share purchase warrant. Each warrant is valid for a period of two years from the date of issuance, at an exercise price of $0.65 per share.

Net proceeds from the financing are to be used primarily for capacity expansion for the firms extraction business as well as for general working capital.

Pure Extracts last traded at $0.72 on the CSE.


FULL DISCLOSURE: Pure Extracts is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Pure Extracts on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Canadian Gold Drills 19.5 g/t Gold Over 1.0 Metre At Lac Arsenault

Canadian Copper Secures Key Approval for Caribou Complex Acquisition

Related News

Pure Extracts Signs LOI For Psychedelic Mushroom Biomass

Pure Extracts (CSE: PULL) has signed a letter of intent for the supply of psychedelic...

Tuesday, March 9, 2021, 09:14:51 AM

Pure Extracts Engages Consultant To Obtain Dealers License

Pure Extracts (CSE: PULL) has engaged a globally recognized operations, compliance and regulatory consulting firm...

Thursday, December 10, 2020, 08:27:56 AM

Pure Extracts Sees Products Submitted To Health Canada For Approval

Pure Extracts (CSE: PULL) is progressing towards revenue generation from the recreational cannabis market. The...

Thursday, February 25, 2021, 07:53:39 AM

Pure Extracts Announces Study Focused on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts (CSE: PULL) this morning announced that it has begun a study focused on...

Wednesday, December 30, 2020, 07:07:46 AM

Pure Extracts Submits Application For First Natural Product Number

Pure Extracts (CSE: PULL) is one step closer to commercializing its functional mushroom operation. The...

Wednesday, February 3, 2021, 07:03:35 AM